Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2025 investor letter. A ...
Fresenius Medical Care AG & Co. FMS reported fourth-quarter 2025 adjusted earnings per share (EPS) of 83 cents, which surpassed the Zacks Consensus Estimate by 23.9%. The bottom line surged 59% year ...
Zacks Investment Research on MSN
Reasons to retain Fresenius Medical stock in your portfolio for now
Fresenius Medical Care AG & Co. FMS is well-positioned for growth, backed by strong profitability improvements from its ...
Fresenius Medical Care AG & Co. FMS reported third-quarter 2025 adjusted earnings per share (EPS) of 64 cents, which surpassed the Zacks Consensus Estimate by 8.47%. The bottom line improved 35.8% ...
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results